Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas
Wenhua Piao(Sapporo Medical University), Kohzoh Imai(Kanagawa Prefectural Hospital Organization), Tadateru Maehata(Sapporo Medical University), David P. Carbone(Vanderbilt University), Arisa Imsumran(Sapporo Medical University), Choon‐Taek Lee(Seoul National University Bundang Hospital), Hiroyuki Yamamoto(Shizuoka Cancer Center), Hua Li(Sapporo Medical University), Rong Li(Kunming Medical University), Yu Wang(Sapporo Medical University), Masanori Li(Sapporo Medical University), Yoshiaki Arimura(Sapporo Medical University), Yasuhisa Shinomura(Sapporo Medical University), Yasushi Adachi(Sapporo Medical University)
Cited by 34
Related Papers
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k
Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2015|1.2k
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
|Cancer Cell|2004|1.1k
Non-small-cell lung cancer
|Nature Reviews Disease Primers|2015|1.1k